Classification & Clinical uses
•3
rd
Generation
•The drugs included in this class are:
•1. Cefotaxime
•2. Ceftriaxone
•3. Ceftazidine
•4. Cefixime
•5. Ceefoperazone
•6. Cefzoxime,
•7. Ceftinir
•Clinical uses
•Third generation: These cephalosporins have assumed an important
role in the treatment of infectious diseases.
•Although they are less potent than frst-generation cephalosporins
against MSSA, the third-generation cephalosporins have enhanced
activity against gram-negative bacilli, including those mentioned
above, as well as most other enteric organisms plus Serratia
marcescens.
•Ceftriaxoneand cefotaximehave become agents of choice in the
treatment of meningitis.
•Ceftazidimehas activity against P. aeruginosa; however, resistance is
increasing and use should be evaluated on a case-by-case basis.
•Third-generation cephalosporins must be used with caution, as they
are associated with signifcant “collateral damage,” essentially
meaning the induction and spread of antimicrobial resistance.
•[Note: Fluoroquinolone use is also associatedwith collateral damage.]
11/29/2020
[email protected] 8